NCT05662020 2022-12-27A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in ChinaBeijing Health Guard Biotechnology, IncPhase 3 Active not recruiting2,750 enrolled